Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-a*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus

Todd M. Allen, John Sidney, Marie France Del Guercio, Rhona L. Glickman, Gary L. Lensmeyer, Donald A. Wiebe, R. DeMars, C. David Pauza, R. Paul Johnson, Alessandro Sette, David Watkins

Research output: Contribution to journalArticle

203 Citations (Scopus)

Abstract

The majority of immunogenic CTL epitopes bind to MHC class I molecules with high affinity. However, peptides longer or shorter than the optimal epitope rarely bind with high affinity. Therefore, identification of optimal CTL epitopes from pathogens may ultimately be critical for inducing strong CTL responses and developing epitope-based vaccines. The SIV-infected rhesus macaque is an excellent animal model for HIV infection of humans. Although a number of CTL epitopes have been mapped in SIV-infected rhesus macaques, the optimal epitopes have not been well defined, and their anchor residues are unknown. We have now defined the optimal SIV gag CTL epitope restricted by the rhesus MHC class I molecule Mamu-A*01 and defined a general peptide binding motif for this molecule that is characterized by a dominant position 3 anchor (proline). We used peptide elution and sequencing, peptide binding assays, and bulk and clonal CTL assays to demonstrate that the optimal Mamu- A*01-restricted SIV gag CTL epitope was CTPYDINQM181-189. Mamu-A*01 is unique in that it is found at a high frequency in rhesus macaques, and all SIV-infected Mamu-A*01-positive rhesus macaques studied to date develop an immunodominant gag-specific CTL response restricted by this molecule. Identification of the optimal SIV gag CTL epitope will be critical for a variety of studies designed to induce CD8+ CTL responses specific for SIV in the rhesus macaque.

Original languageEnglish
Pages (from-to)6062-6071
Number of pages10
JournalJournal of Immunology
Volume160
Issue number12
StatePublished - Jun 15 1998
Externally publishedYes

Fingerprint

Immunodominant Epitopes
Simian Immunodeficiency Virus
Epitopes
Peptides
Macaca mulatta
Proline
HIV Infections
Vaccines
Animal Models

ASJC Scopus subject areas

  • Immunology

Cite this

Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-a*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. / Allen, Todd M.; Sidney, John; Del Guercio, Marie France; Glickman, Rhona L.; Lensmeyer, Gary L.; Wiebe, Donald A.; DeMars, R.; Pauza, C. David; Johnson, R. Paul; Sette, Alessandro; Watkins, David.

In: Journal of Immunology, Vol. 160, No. 12, 15.06.1998, p. 6062-6071.

Research output: Contribution to journalArticle

Allen, TM, Sidney, J, Del Guercio, MF, Glickman, RL, Lensmeyer, GL, Wiebe, DA, DeMars, R, Pauza, CD, Johnson, RP, Sette, A & Watkins, D 1998, 'Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-a*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus', Journal of Immunology, vol. 160, no. 12, pp. 6062-6071.
Allen, Todd M. ; Sidney, John ; Del Guercio, Marie France ; Glickman, Rhona L. ; Lensmeyer, Gary L. ; Wiebe, Donald A. ; DeMars, R. ; Pauza, C. David ; Johnson, R. Paul ; Sette, Alessandro ; Watkins, David. / Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-a*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. In: Journal of Immunology. 1998 ; Vol. 160, No. 12. pp. 6062-6071.
@article{19f7befade1543e39a70dc180f3b171c,
title = "Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-a*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus",
abstract = "The majority of immunogenic CTL epitopes bind to MHC class I molecules with high affinity. However, peptides longer or shorter than the optimal epitope rarely bind with high affinity. Therefore, identification of optimal CTL epitopes from pathogens may ultimately be critical for inducing strong CTL responses and developing epitope-based vaccines. The SIV-infected rhesus macaque is an excellent animal model for HIV infection of humans. Although a number of CTL epitopes have been mapped in SIV-infected rhesus macaques, the optimal epitopes have not been well defined, and their anchor residues are unknown. We have now defined the optimal SIV gag CTL epitope restricted by the rhesus MHC class I molecule Mamu-A*01 and defined a general peptide binding motif for this molecule that is characterized by a dominant position 3 anchor (proline). We used peptide elution and sequencing, peptide binding assays, and bulk and clonal CTL assays to demonstrate that the optimal Mamu- A*01-restricted SIV gag CTL epitope was CTPYDINQM181-189. Mamu-A*01 is unique in that it is found at a high frequency in rhesus macaques, and all SIV-infected Mamu-A*01-positive rhesus macaques studied to date develop an immunodominant gag-specific CTL response restricted by this molecule. Identification of the optimal SIV gag CTL epitope will be critical for a variety of studies designed to induce CD8+ CTL responses specific for SIV in the rhesus macaque.",
author = "Allen, {Todd M.} and John Sidney and {Del Guercio}, {Marie France} and Glickman, {Rhona L.} and Lensmeyer, {Gary L.} and Wiebe, {Donald A.} and R. DeMars and Pauza, {C. David} and Johnson, {R. Paul} and Alessandro Sette and David Watkins",
year = "1998",
month = "6",
day = "15",
language = "English",
volume = "160",
pages = "6062--6071",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "12",

}

TY - JOUR

T1 - Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-a*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus

AU - Allen, Todd M.

AU - Sidney, John

AU - Del Guercio, Marie France

AU - Glickman, Rhona L.

AU - Lensmeyer, Gary L.

AU - Wiebe, Donald A.

AU - DeMars, R.

AU - Pauza, C. David

AU - Johnson, R. Paul

AU - Sette, Alessandro

AU - Watkins, David

PY - 1998/6/15

Y1 - 1998/6/15

N2 - The majority of immunogenic CTL epitopes bind to MHC class I molecules with high affinity. However, peptides longer or shorter than the optimal epitope rarely bind with high affinity. Therefore, identification of optimal CTL epitopes from pathogens may ultimately be critical for inducing strong CTL responses and developing epitope-based vaccines. The SIV-infected rhesus macaque is an excellent animal model for HIV infection of humans. Although a number of CTL epitopes have been mapped in SIV-infected rhesus macaques, the optimal epitopes have not been well defined, and their anchor residues are unknown. We have now defined the optimal SIV gag CTL epitope restricted by the rhesus MHC class I molecule Mamu-A*01 and defined a general peptide binding motif for this molecule that is characterized by a dominant position 3 anchor (proline). We used peptide elution and sequencing, peptide binding assays, and bulk and clonal CTL assays to demonstrate that the optimal Mamu- A*01-restricted SIV gag CTL epitope was CTPYDINQM181-189. Mamu-A*01 is unique in that it is found at a high frequency in rhesus macaques, and all SIV-infected Mamu-A*01-positive rhesus macaques studied to date develop an immunodominant gag-specific CTL response restricted by this molecule. Identification of the optimal SIV gag CTL epitope will be critical for a variety of studies designed to induce CD8+ CTL responses specific for SIV in the rhesus macaque.

AB - The majority of immunogenic CTL epitopes bind to MHC class I molecules with high affinity. However, peptides longer or shorter than the optimal epitope rarely bind with high affinity. Therefore, identification of optimal CTL epitopes from pathogens may ultimately be critical for inducing strong CTL responses and developing epitope-based vaccines. The SIV-infected rhesus macaque is an excellent animal model for HIV infection of humans. Although a number of CTL epitopes have been mapped in SIV-infected rhesus macaques, the optimal epitopes have not been well defined, and their anchor residues are unknown. We have now defined the optimal SIV gag CTL epitope restricted by the rhesus MHC class I molecule Mamu-A*01 and defined a general peptide binding motif for this molecule that is characterized by a dominant position 3 anchor (proline). We used peptide elution and sequencing, peptide binding assays, and bulk and clonal CTL assays to demonstrate that the optimal Mamu- A*01-restricted SIV gag CTL epitope was CTPYDINQM181-189. Mamu-A*01 is unique in that it is found at a high frequency in rhesus macaques, and all SIV-infected Mamu-A*01-positive rhesus macaques studied to date develop an immunodominant gag-specific CTL response restricted by this molecule. Identification of the optimal SIV gag CTL epitope will be critical for a variety of studies designed to induce CD8+ CTL responses specific for SIV in the rhesus macaque.

UR - http://www.scopus.com/inward/record.url?scp=15444357765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15444357765&partnerID=8YFLogxK

M3 - Article

C2 - 9637523

AN - SCOPUS:15444357765

VL - 160

SP - 6062

EP - 6071

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 12

ER -